Therini Bio
PrivateLast Round
Series A
Extension
May 14, 2025
Total Funding Raised
$107.32M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Therini Bio is a biotechnology company developing fibrin-targeting immunotherapies to treat neuroinflammatory and retinal diseases driven by vascular dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Therini Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Therini Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 14, 2025 | ||||
| Series A | Apr 27, 2023 | ||||
| Grant | Sep 1, 2021 | ||||
| Seed | May 10, 2021 | ||||
| Seed | Feb 24, 2020 |
Therini Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apollo Ventures | Series A Extension |
| Dolby Family Ventures | Series A Extension, Series A, Seed |
| SV Health Investors | Series A Extension, Series A, Seed |
| NIH RADx | Grant |
| Blue Goose Capital | Series A Extension |
| National MS Society | Seed |
| The Foundation For A Better World | Series A Extension, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
Grew 25% QoQ, from 12 to 15 employees.
- May 13, 2026
Monthly visitors grew 391% MoM, from 250 to 1.2K.
Therini Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Therini Bio's valuation, stock price, and market status.